Hsbc Holdings PLC Catalyst Biosciences, Inc. Transaction History

Hsbc Holdings PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	BUY	$4.1 - $5.33 $20,848 - $27,103	5,085 Added 18.53%	32,528 $140,000
Q1 2021 May 14, 2021	BUY	$4.93 - $7.15 $25,256 - $36,629	5,123 Added 22.95%	27,443 $138,000
Q4 2020 Feb 12, 2021	BUY	$4.55 - $7.29 $2,607 - $4,177	573 Added 2.63%	22,320 $140,000
Q3 2020 Nov 12, 2020	BUY	$4.22 - $6.04 $44,360 - $63,492	10,512 Added 93.56%	21,747 $97,000
Q2 2020 Aug 14, 2020	BUY	$3.76 - $8.01 $42,243 - $89,992	11,235 New	11,235 $66,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.